The Role of Mobile Health Technologies in Allergy Care: an EAACI Position Paper
Matricardi, Paolo Maria; Dramburg, Stephanie; Alvarez-Perea, Alberto; AntolÃn-Amérigo, DarÃo; Apfelbacher, Christian; Atanaskovic-Markovic, Marina; Berger, Uwe; Blaiss, Michael S; Blank, Simon; Boni, Elisa; Bonini, Matteo; Bousquet, Jean; Brockow, Knut; Buters, Jeroen; Cardona, Victoria; Caubet, Jean-Christoph; Cavkaytar, Özlem; Elliott, Tania; Esteban-Gorgojo, Ignacio; Fonseca, Joao A; Gardner, James; Gevaert, Philippe; Ghiordanescu, Ileana; Hellings, Peter; Hoffmann-Sommergruber, Karin; Kalpaklioglu, A Fusun; Marmouz, Farid; Meijide Calderón, Ãngela; Mösges, Ralph; Nakonechna, Alla; Ollert, Markus; Oteros, José; Pajno, Giovanni; Panaitescu, Catalina; Perez-Formigo, Daniel; Pfaar, Oliver; Pitsios, Constantinos; Rudenko, Michael; Ryan, Dermot; Sánchez-GarcÃa, Silvia; Shih, Jennifer; Tripodi, Salvatore; Van der Poel, Lauri-Ann; van Os-Medendorp, Harmieke; Varricchi, Gilda; Wittmann, Jörn; Worm, Margitta; Agache, Ioana
Mobile Health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data flow and information, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the "Be He@lthy, Be Mobile" WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the "General Data Protection Regulation" and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of health care professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician- to patient-centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts, recommendations, and an action plan for future mHealth initiatives within EAACI are listed. This article is protected by copyright. All rights reserved.
PMID: 31230373
ISSN: 1398-9995
CID: 3963502
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis
Chu, V H; Park, L P; Athan, E; Delahaye, F; Freiberger, T; Lamas, C; Mudrick, D W; Strahilevitz, J; Tribouilloy, C; Durante-Mangoni, E; Pericas, J M; Fernandez-Hidalgo, N; Nacinovich, F; Rizk, H; Krajinovic, V; Giannitsioti, E; Hurley, J P; Hannan, M M; Wang, A; Clara, L; Sanchez, M; Casabe, J; Cortes, C; Oses, P F; Ronderos, R; Sucari, A; Thierer, J; Altclas, J; Kogan, S; Spelman, D; Harris, O; Kennedy, K; Tan, R; Papanicolas, L; Korman, T; Kotsanas, D; Dever, R; Jones, P; Konecny, P; Lawrence, R; Rees, D; Ryan, S; Feneley, M P; Harkness, J; Post, J; Reinbott, P; Gattringer, R; Wiesbauer, F; Andrade, A R; de, Brito A C P; Guimaraes, A C; Grinberg, M; Mansur, A J; Siciliano, R F; Strabelli, T M V; Vieira, M L C; de, Medeiros Tranchesi R A; Paiva, M G; Fortes, C Q; de, Oliveira Ramos A; Ferraiuoli, G; Golebiovski, W; Weksler, C; Karlowsky, J A; Keynan, Y; Morris, A M; Rubinstein, E; Jones, S B; Garcia, P; Cereceda, M; Mella, R M; Fernandez, R; Franco, L; Gonzalez, J; Jaramillo, A N; Barsic, B; Bukovski, S; Rudez, I; Vincelj, J; Pol, J; Malisova, B; Ashour, Z; El, Kholy A; Mishaal, M; Osama, D; Aissa, N; Alauzet, C; Alla, F; Campagnac, C; Doco-Lecompte, T; Selton-Suty, C; Casalta, J -P; Fournier, P -E; Habib, G; Raoult, D; Thuny, F; Delahaye, A; Vandenesch, F; Donal, E; Donnio, P Y; Flecher, E; Michelet, C; Revest, M; Tattevin, P; Chevalier, F; Jeu, A; Remadi, J P; Rusinaru, D; Bernard, Y; Chirouze, C; Hoen, B; Leroy, J; Plesiat, P; Naber, C; Neuerburg, C; Mazaheri, B; Athanasia, S; Giamarellou, H; Thomas, T; Mylona, E; Paniara, O; Papanicolaou, K; Pyros, J; Skoutelis, A; Papanikolaou, K; Sharma, G; Francis, J; Nair, L; Thomas, V; Venugopal, K; Cahan, A; Gilon, D; Israel, S; Korem, M; Mattucci, I; Pinto, D; Agrusta, F; Senese, A; Ragone, E; Utili, R; Cecchi, E; De, Rosa F; Forno, D; Imazio, M; Trinchero, R; Grossi, P; Lattanzio, M; Toniolo, A; Goglio, A; Raglio, A; Ravasio, V; Rizzi, M; Suter, F; Carosi, G; Magri, S; Signorini, L; Kanafani, Z; Kanj, S S; Sharif-Yakan, A; Abidin, I; Tamin, S S; Martinez, E R; Nieto, G I S; van, der Meer J T M; Chambers, S; Holland, D; Morris, A; Raymond, N; Read, K; Murdoch, D R; Dragulescu, S; Ionac, A; Mornos, C; Butkevich, O M; Chipigina, N; Kirill, O; Vadim, K; Vinogradova, T; Edathodu, J; Halim, M; Liew, Y Y; Tan, R -S; Lejko-Zupanc, T; Logar, M; Mueller-Premru, M; Commerford, P; Commerford, A; Deetlefs, E; Hansa, C; Ntsekhe, M; Almela, M; Armero, Y; Azqueta, M; Castaneda, X; Cervera, C; Falces, C; Garcia-dela-Maria, C; Fita, G; Gatell, J M; Heras, M; Llopis, J; Marco, F; Mestres, C A; Miro, J M; Moreno, A; Ninot, S; Pare, C; Ramirez, J; Rovira, I; Sitges, M; Anguera, I; Font, B; Guma, J R; Bermejo, J; Bouza, E; Fernandez, M A G; Gonzalez-Ramallo, V; Marin, M; Munoz, P; Pedromingo, M; Roda, J; Rodriguez-Creixems, M; Solis, J; Almirante, B; Tornos, P; de, Alarcon A; Parra, R; Alestig, E; Johansson, M; Olaison, L; Snygg-Martin, U; Pachirat, O; Pachirat, P; Pussadhamma, B; Senthong, V; Casey, A; Elliott, T; Lambert, P; Watkin, R; Eyton, C; Klein, J L; Bradley, S; Kauffman, C; Bedimo, R; Corey, G R; Crowley, A L; Douglas, P; Drew, L; Fowler, V G; Holland, T; Lalani, T; Samad, Z; Sexton, D J; Stryjewski, M; Woods, C W; Lerakis, S; Cantey, R; Steed, L; Wray, D; Dickerman, S A; Bonilla, H; DiPersio, J; Salstrom, S -J; Baddley, J; Patel, M; Peterson, G; Stancoven, A; Levine, D; Riddle, J; Rybak, M; Cabell, C H; Baloch, K; Dixon, C C; Harding, T; Jones-Richmond, M; Sanderford, B; Stafford, J; Anstrom, K; Bayer, A S; Karchmer, A W; Durack, D T; Eykyn, S; Moreillon, P
Background-Use of surgery for the treatment of infective endocarditis (IE) as related to surgical indications and operative risk for mortality has not been well defined. Methods and Results-The International Collaboration on Endocarditis-PLUS (ICE-PLUS) is a prospective cohort of consecutively enrolled patients with definite IE from 29 centers in 16 countries. We included patients from ICE-PLUS with definite left-sided, non-cardiac device-related IE who were enrolled between September 1, 2008, and December 31, 2012. A total of 1296 patients with left-sided IE were included. Surgical treatment was performed in 57% of the overall cohort and in 76% of patients with a surgical indication. Reasons for nonsurgical treatment included poor prognosis (33.7%), hemodynamic instability (19.8%), death before surgery (23.3%), stroke (22.7%), and sepsis (21%). Among patients with a surgical indication, surgical treatment was independently associated with the presence of severe aortic regurgitation, abscess, embolization before surgical treatment, and transfer from an outside hospital. Variables associated with nonsurgical treatment were a history of moderate/severe liver disease, stroke before surgical decision, and Staphyloccus aureus etiology. The integration of surgical indication, Society of Thoracic Surgeons IE score, and use of surgery was associated with 6-month survival in IE. Conclusions-Surgical decision making in IE is largely consistent with established guidelines, although nearly one quarter of patients with surgical indications do not undergo surgery. Operative risk assessment by Society of Thoracic Surgeons IE score provides prognostic information for survival beyond the operative period. S aureus IE was significantly associated with nonsurgical management.
Copyright
EMBASE:603858735
ISSN: 0009-7322
CID: 4984472